JAPAN PHARMACEUTICAL LOGISTICS MARKET FORECAST 2024-2032
SCOPE OF THE REPORT
Japan Pharmaceutical Logistics Market by Product (Branded Drugs, Generic Drugs, OTC) Market by Therapy Area (Communicable Diseases, Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, Pain Management, Respiratory Diseases, Other Therapy Areas) Market by Type (Non-cold Chain Logistics, Cold Chain Logistics) Market by Component (Storage, Transportation, Monitoring Components)
REPORTS » LOGISTICS & SUPPLY CHAIN » SUPPLY CHAIN MANAGEMENT » JAPAN PHARMACEUTICAL LOGISTICS MARKET FORECAST 2024-2032
MARKET OVERVIEW
The Japan pharmaceutical logistics market is projected to grow at a CAGR of 8.62% over the forecast period of 2024-2032. It is positioned to reach a revenue of $11771.75 million by 2032.
The pharmaceutical logistics market in Japan is a rapidly evolving sector intricately tied to the country’s robust pharmaceutical industry and stringent regulatory standards. As one of the world’s leading markets for pharmaceuticals, the logistics infrastructure supporting this industry plays a pivotal role. It ensures the timely and efficient distribution of medical products across the nation.
Japan’s pharmaceutical logistics sphere emphasizes quality control, temperature-sensitive handling, and regulatory compliance. Given the nature of pharmaceutical products, which often require specific storage conditions and handling protocols, logistics providers in Japan must adhere to strict guidelines. These guidelines are crucial to maintain product integrity throughout the supply chain. This focus on quality and regulatory adherence has contributed significantly to Japan’s reputation for reliable and safe pharmaceutical distribution.
![Japan Pharmaceutical Logistics Market](https://inkwoodresearch.com/wp-content/uploads/edd/2024/05/Japan-Pharmaceutical-Logistics-Market-1024x683.jpg)
To Know More About This Report, Request a Free Sample Copy
The emergence of advanced technologies, such as temperature-controlled storage facilities, real-time tracking systems, and data analytics, has revolutionized the pharmaceutical logistics sector in Japan. These innovations enhance the efficiency of supply chain operations and enable better inventory management, risk mitigation, and responsiveness to market demands. As Japan continues to invest in modern logistics solutions, the industry is inclined to further growth and optimization.
Moreover, Japan’s pharmaceutical logistics market is witnessing increased collaboration and partnerships among industry stakeholders. This includes collaborations between logistics providers, pharmaceutical companies, government agencies, and technology firms. They work together to develop integrated solutions that address the evolving needs of the healthcare sector. Such collaborations foster innovation, improve supply chain visibility and ultimately benefit patients by ensuring timely access to vital medications.
The Japan pharmaceutical logistics market segmentation incorporates the market by product, therapy area, type, and component. The therapy area segment is further divided into communicable diseases, oncology, diabetes, cardiovascular diseases, autoimmune diseases, neurological disorders, pain management, respiratory diseases, and other therapy areas. Communicable diseases encompass logistics operations related to infectious diseases, vaccinations, and public health initiatives. The logistics challenges in this sub-segment often revolve around the timely and safe distribution of vaccines, medications, and medical supplies to combat outbreaks and ensure population health.
Oncology stands out as another crucial therapy area within the market. Logistics in oncology focuses on the efficient handling and delivery of cancer treatments, including chemotherapy drugs, biologics, and supportive care medications. The complexity of oncology logistics is multifaceted, including stringent temperature control requirements for certain drugs. It also involves the need for rapid delivery to support treatment schedules and the management of specialized packaging and handling protocols to ensure drug efficacy and patient safety.
Cardiovascular diseases include medications for hypertension, heart disease, stroke prevention, and related conditions. Logistics operations in cardiovascular care focus on supply chain efficiency, inventory management, and distribution networks that prioritize timely delivery to healthcare facilities and pharmacies. With the rising prevalence of cardiovascular diseases globally, the logistics sector plays a vital role. It ensures continuous access to life-saving medications and therapies for patients in Japan, highlighting the critical importance of efficient pharmaceutical logistics in healthcare delivery.
Some of the leading players in the Japan pharmaceutical logistics market include DSV, DB Schenker, Deutsche Post AG, FedEx, Kuehne + Nagel, etc.
DSV, headquartered in Hedehusene, Denmark, is a leading logistics and transport company offering global road, sea, air, and rail transportation services. It serves industries like technology, automotive, healthcare, pharmaceuticals, industrial, renewable energy, and retail and fashion, with a presence in over 80 countries. DSV specializes in healthcare logistics, including pharma cold chain, hospital deliveries, medical device transport, and biopharma logistics. It operates through air and sea, road, and solutions segments, providing comprehensive logistics solutions worldwide.
REPORT SYNOPSIS
REPORT SCOPE | DETAILS |
---|---|
Market Forecast Years | 2024-2032 |
Base Year | 2023 |
Market Historical Years | 2018-2022 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Product, Therapy Area, Type, and Component |
Countries Analyzed | Japan |
Companies Analyzed | AP Moller – Maersk, Cardinal Health, CEVA Logistics, DB Schenker, Deutsche Post AG, DSV, FedEx, Kuehne + Nagel, Medline, SEKO Logistics, United Parcel Service (UPS) |
RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- MAJOR MARKET FINDINGS
- BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
- COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
- COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
- MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA
MARKET DYNAMICS
- KEY DRIVERS
- RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
- EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
- RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
- SURGE IN PHARMACEUTICAL LOGISTICS DURING THE JAPAN COVID-19 PANDEMIC
- KEY RESTRAINTS
- RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
- ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS
- KEY DRIVERS
KEY ANALYTICS
- KEY MARKET TRENDS
- SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
- REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
- INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING FOR JAPAN
- MARKET CONCENTRATION ANALYSIS
- VALUE CHAIN ANALYSIS
- MANUFACTURING
- STORAGE
- TRANSPORTATION
- DISTRIBUTION
- MONITORING COMPONENTS
- CONSUMPTION
- KEY BUYING CRITERIA
- TYPE OF LOGISTICS
- SERVICES OFFERED
- MODE OF TRANSPORTATION
- APPLICATION
- REGULATORY COMPLIANCE
- TECHNOLOGICAL CAPABILITIES
- COST
- RELIABILITY
- AGILITY
- KEY MARKET TRENDS
MARKET BY PRODUCT
- BRANDED DRUGS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- GENERIC DRUGS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTC
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- BRANDED DRUGS
MARKET BY THERAPY AREA
- COMMUNICABLE DISEASES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- ONCOLOGY
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- DIABETES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- CARDIOVASCULAR DISEASES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AUTOIMMUNE DISEASES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- NEUROLOGICAL DISORDERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- PAIN MANAGEMENT
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RESPIRATORY DISEASES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTHER THERAPY AREAS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- COMMUNICABLE DISEASES
MARKET BY TYPE
- NON-COLD CHAIN LOGISTICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- COLD CHAIN LOGISTICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- NON-COLD CHAIN LOGISTICS
MARKET BY COMPONENT
- STORAGE
- WAREHOUSE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- REFRIGERATED CONTAINERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- WAREHOUSE
- TRANSPORTATION
- OVERLAND LOGISTICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SEA FREIGHT LOGISTICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AIR FREIGHT LOGISTICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OVERLAND LOGISTICS
- MONITORING COMPONENTS
- HARDWARE
- SENSORS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RFID DEVICES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- TELEMATICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- NETWORKING DEVICES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SENSORS
- SOFTWARE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- HARDWARE
- STORAGE
COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
- AP MOLLER – MAERSK
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- CARDINAL HEALTH
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- CEVA LOGISTICS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- DB SCHENKER
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- DEUTSCHE POST AG
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- DSV
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- FEDEX
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- KUEHNE + NAGEL
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- MEDLINE
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- SEKO LOGISTICS
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- UNITED PARCEL SERVICE (UPS)
- COMPANY OVERVIEW
- PRODUCT PORTFOLIO
- STRENGTHS & CHALLENGES
- AP MOLLER – MAERSK
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL LOGISTICS
TABLE 2: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: JAPAN STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: JAPAN STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: JAPAN TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: JAPAN TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: JAPAN MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: JAPAN MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: JAPAN HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: JAPAN HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 9: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 11: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023
FIGURE 12: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 13: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 15: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 16: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 17: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)
FIGURE 18: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 19: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 20: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)
FIGURE 21: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 22: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 23: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 24: JAPAN PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023
FIGURE 25: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 26: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 27: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)
FIGURE 28: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 29: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 30: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 31: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 32: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)
FIGURE 33: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 34: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 35: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 36: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 37: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 38: JAPAN PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)
FAQ’s
RELATED REPORTS
-
CHINA BATTERY MARKET FORECAST 2024-2032
-
GERMANY BATTERY MARKET FORECAST 2024-2032
-
UNITED STATES AEROSPACE ROBOTICS MARKET FORECAST 2024-2032
-
FRANCE AEROSPACE ROBOTICS MARKET FORECAST 2024-2032
-
CHINA AEROSPACE ROBOTICS MARKET FORECAST 2024-2032
-
GERMANY RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET FORECAST 2024-2032
-
SOUTH KOREA RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET FORECAST 2024-2032
-
UNITED KINGDOM RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET FORECAST 2024-2032
-
JAPAN ENTERPRISE RESOURCE PLANNING (ERP) MARKET FORECAST 2024-2032
-
FINLAND ENTERPRISE RESOURCE PLANNING (ERP) MARKET FORECAST 2024-2032